← Back to headlines
Immunic Progresses Phase 3 MS Program, Aims for Year-End Data
Immunic has announced advancements in its Phase 3 multiple sclerosis program and anticipates releasing topline data by the end of the year.
13 May, 13:04 — 13 May, 13:04
Sources
Showing 1 of 1 sources
